Topically applied rhGM-CSF for the wound healing: a systematic review

Area of Science:

• Regenerative Medicine
• Dermatology
• Wound Care

Background:

• Wound healing is a complex biological process involving cellular and molecular interactions.
• Granulocyte-macrophage colony-stimulating factor (GM-CSF) plays a crucial role in wound repair mechanisms.
• Topical rhGM-CSF has shown promise in treating various wound types.

Purpose of the Study:

• To systematically review and analyze the evidence on the efficacy of topical rhGM-CSF in wound healing.
• To evaluate the effects of rhGM-CSF across different wound etiologies.

Main Methods:

• Systematic review and meta-analysis of randomized controlled trials (RCTs).
• Inclusion of clinical studies and case reports for comprehensive evidence analysis.
• Data synthesis to assess the overall impact of rhGM-CSF on wound closure and healing parameters.

Main Results:

• Topical rhGM-CSF demonstrates significant benefits for deep partial-thickness burns, chronic venous leg ulcers, and leprosy ulcers.
• Potential positive effects noted for pressure ulcers and cancer-related ulcers, though evidence is currently insufficient for widespread application.
• rhGM-CSF does not appear to accelerate the healing of healthy wounds or surgical incisions.

Conclusions:

• Topical rhGM-CSF is a promising therapeutic agent for specific chronic and severe wound types.
• Further research is needed to establish the efficacy of rhGM-CSF for pressure ulcers and other chronic wound categories.
• rhGM-CSF is not indicated for accelerating the healing of healthy or surgically incised wounds.